Endothelial dysfunction in patients with obstructive sleep apnea Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism Year: 2011
Prevalence of obstructive airway disease in patients with obstructive sleep apnea Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA Year: 2012
Roles of periostin in patients with severe obstructive sleep apnea Source: International Congress 2017 – New pathophysiological insights: intermittent hypoxia, cardiopulmonary function and biomarkers Year: 2017
Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010
Bronchial inflammation in obstructive sleep apnea (OSA) patients Source: Eur Respir J 2003; 22: Suppl. 45, 466s Year: 2003
Unrecognised systemic hypertension in patients with obstructive sleep apnoea Source: Eur Respir J 2006; 28: Suppl. 50, 643s Year: 2006
Unrecognised hypertension in patients screened for obstructive sleep apnoea Source: Eur Respir J 2005; 26: Suppl. 49, 40s Year: 2005
Unrecognised obstructive sleep apnoea is common in severe peripheral arterial disease Source: Eur Respir J 2013; 41: 616-620 Year: 2013
Chronic obstructive pulmonary disease in patients with obstructive sleep apnea Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep Year: 2009
Airway inflammation in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 274s Year: 2002
Arterial hypertension in patients with obstructive sleep apnoea and overlap syndrome Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep Year: 2009
Autoantibody against NBL1 in obstructive sleep apnea patients with cardiovascular disease Source: International Congress 2017 – New insights into the understanding of sleep and the consequences of sleep apnoea Year: 2017
Markers of liver dysfunction in patients with obstructive sleep apnea Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism Year: 2011
Efficacy of AUTO-CPAP titration in patients with obstructive sleep apnoea and chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 390s Year: 2001
Prevalence of stroke in obstructive sleep apnoea (OSA) patients Source: Eur Respir J 2007; 30: Suppl. 51, 331s Year: 2007
Vasoconstriction during the night in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 419s Year: 2006
Clinical phenotypes in patients with concomitant obstructive sleep apnea and chronic obstructive pulmonary disease Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD Year: 2012
The vascular micromilieu in obstructive sleep apnoea Source: Eur Respir J 2005; 25: 780-782 Year: 2005
Prevalance of daytime hypercapnia in patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 574s Year: 2002
The impact of obstructive sleep apnoea syndrome on endothelial function in patients with moderate and severe hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 39s Year: 2005